Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Other

Neurology, biomanufacturing start-ups bag UK AI funding

 April 22, 2026

Pharmaphorum

The first recipients of the UK government’s 500 million Sovereign AI fund have been announced, including two life sciences-focused start-ups.

OtherNeuroscienceRead full story

Post navigation

Ionis’ antisense drug stabilizes ultra-rare disease ahead of FDA decision →
← Trump’s psychedelics push a mixed blessing for neuropsychiatric companies, patients

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com